There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:C12Q1/6886
Jump to navigation
Jump to search
Subcategories
This category has the following 23 subcategories, out of 23 total.
A
D
E
F
H
J
K
L
M
R
S
U
Pages in category "C12Q1/6886"
The following 57 pages are in this category, out of 57 total.
1
- 18004030. METHYLATED MARKERS FOR ACCURATE DETECTION OF PRIMARY CENTRAL NERVOUS SYSTEM AND SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA simplified abstract (THE JOHNS HOPKINS UNIVERSITY)
- 18261638. USE OF IMMUNE CONTENT SCORES DIAGNOSTICALLY TO PREDICT RESPONSIVENESS OF PROSTATE CANCER PATIENTS TO IMMUNOTHERAPY simplified abstract (NORTHWESTERN UNIVERSITY)
- 18264314. METHODS AND BIOMARKERS IN CANCER simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18363584. MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS simplified abstract (THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY)
- 18435880. Methods and Systems for Analyzing Nucleic Acid Molecules simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 18457634. CANCER EXAMINATION REAGENT SET, PRODUCTION METHOD FOR CANCER EXAMINATION REAGENT SET, AND CANCER EXAMINATION METHOD simplified abstract (FUJIFILM Corporation)
- 18461820. MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18464360. C-RAF Mutants that Confer Resistance to RAF Inhibitors simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18524141. METHOD OF IDENTIFYING FEATURE OF TEST BODY AND MICRORNA CANCER MARKER simplified abstract (KABUSHIKI KAISHA TOSHIBA)
- 18544232. Methods and Systems for Detecting Biological Components simplified abstract (The Regents of the University of California)
- 18548025. METHYLATION MARKERS FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS simplified abstract (Duke University)
- 18558992. COMPOSITIONS COMPRISING NULLOMERS AND METHODS OF USING THE SAME FOR CANCER DETECTION AND DIAGNOSIS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC)
- 18579487. MYCOBIOME IN CANCER simplified abstract (The Regents of the University of California)
- 18706482. EXTRACELLULAR RNA SIGNATURES OF MUTANT KRAS(G12C) CANCERS (The Regents of the University of California)
- 18710819. MITOCHONDRIAL GENOTYPICAL SCORES: PROGNOSTIC MARKERS IN CHEMOSENSITIVE CANCER (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE)
- 18713351. USE OF A TRANSCRIPTOMIC SIGNATURE BASED ON HERVs EXPRESSION TO CHARACTERIZE NEW ACUTE MYELOID LEUKEMIA SUBTYPES (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE)
- 18786314. METHYLATION MARKERS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA AND LUNG CANCER (The Regents of the University of California)
- 18815119. NON-INVASIVE CLASSIFICATION OF BENIGN AND MALIGNANT MELANOCYTIC LESIONS USING MICRORNA PROFILING (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18821460. COMPOSITIONS AND METHODS FOR TREATING CANCER (The Regents of the University of California)
- 18962201. PANCREATIC CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD (TORAY INDUSTRIES, INC.)
2
- 20240026462. HOMOLOGOUS RECOMBINATION DEFICIENCY DETERMINING METHOD AND KIT THEREOF simplified abstract (ACT GENOMICS (IP) LIMITED)
- 20240043938. BIOMARKER PANEL AND METHODS FOR DETECTING MICROSATELLITE INSTABILITY IN CANCERS simplified abstract (Biocartis NV)
- 20240052423. METHODS OF IDENTIFYING A TUMOR THAT IS SENSITIVE TO TREATMENT WITH TALAZOPARIB AND METHODS OF TREATMENT THEREOF simplified abstract (Pfizer Inc.)
A
- Accessibility patent applications on 28th Feb 2025
- Accessibility patent applications on February 27th, 2025
- Accessibility patent applications on June 27th, 2024
- Accessibility patent applications on May 16th, 2024
- Amazon technologies, inc. (20250003004). Personalized Longitudinal Analysis of Circulating Material to Monitor and Adapt Neoantigen Cancer Vaccines
- Amazon technologies, inc. (20250019766). TUMOR CELL IDENTIFICATION BY MAPPING MUTATIONS IN BULK DNA SEQUENCES TO SINGLE CELL RNA SEQUENCES
- Amazon Technologies, Inc. patent applications on January 16th, 2025
- Amazon Technologies, Inc. patent applications on January 2nd, 2025
B
- Biotechnology patent applications on October 24th, 2024
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on February 15th, 2024
- Blockchain patent applications on February 8th, 2024
- Blockchain patent applications on January 25th, 2024
- Blockchain patent applications on March 14th, 2024
- Blockchain patent applications on March 28th, 2024
- BRCA1 patent applications on 26th Jul 2024
- BRCA1 patent applications on July 25th, 2024
K
T
- The regents of the university of california (20240252652). PROTEINS HAVING UNNATURAL AMINO ACIDS AND METHODS OF USE simplified abstract
- The regents of the university of california (20240339216). MYCOBIOME IN CANCER simplified abstract
- The regents of the university of california (20240410019). CLUSTERED MUTATIONS FOR THE TREATMENT OF CANCER
- The regents of the university of california (20250092061). COMPOSITIONS AND METHODS FOR TREATING CANCER
- The Regents of the University of California patent applications on August 1st, 2024
- The Regents of the University of California patent applications on December 12th, 2024
- The Regents of the University of California patent applications on March 20th, 2025
- The Regents of the University of California patent applications on October 10th, 2024
- THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (20240209455). ANALYSIS OF FRAGMENT ENDS IN DNA simplified abstract
U
- UNION HOSPITAL TONGJI MEDICAL COLLEGE HUST (20240352531). METHOD FOR DETECTING CD19 EXPRESSION simplified abstract
- US Patent Application 17815514. ANTI-CD46 ANTIBODIES AND METHODS OF USE simplified abstract
- US Patent Application 18248757. METHODS TO PREDICT OUTCOMES TO CHIMERIC ANTIGEN RECEPTOR T-CELLS IN LYMPHOMA FROM CELL-FREE DNA AND GENETIC MUTATIONS simplified abstract
